On February 6, 2018, Acasta Enterprises Inc. (TSX: AEF) (“Acasta” or the “Company”) announced it entered into a non-binding term sheet (the “Term Sheet”) with Martello Finance Company Limited to sell Stellwagen Group Limited (“Stellwagen”) and an amending agreement (the “Amending Agreement”) to its U.S. $150 million credit facility (the “Credit Facility”).
InMed Pharmaceuticals Inc. ("InMed" or the "Company") (CSE:IN; OTCQB:IMLFF), a biopharmaceutical company specializing in the research and development of novel, cannabinoid-based drug therapies, announced today that it has received conditional approval from the Toronto Stock Exchange (the "TSX") to list its common shares ("Common Shares") on the TSX.
Acerus Pharmaceuticals Corporation (TSX:ASP) (“Acerus” or the “Company”) announced that the Divisional Court of the Ontario Superior Court of Justice has dismissed the appeal brought by Mr. Eugene Melnyk of the Order of the Honourable Justice Wilton-Siegel dismissing Mr. Melnyk’s motion for leave to commence a derivative action in the name of the Company against certain of the Company’s directors and officers.
VersaBank (TSX: VB, VB.PR.A, VB.PR.B) (“VersaBank”) announced today that it has hired Upneet Singh as a Cyber Security Lead focusing on Security Vulnerabilities and Penetration Testing to join VersaVault’s senior cyber security team developing its Blockchain based vault initiative to securely store digital property.